BioUtah, the trade association representing Utah's life sciences community, will participate in the J.P. Morgan 44th Annual Healthcare Conference from January 11-16, 2026, in San Francisco. BioUtah President and CEO Kelvyn Cullimore will attend on behalf of the association, representing more than 1,600 life sciences companies across the state. Utah's industry strengths include medical device manufacturing, diagnostics, biotechnology, pharmaceuticals, and digital health.
The conference represents a significant opportunity for Utah's life sciences sector to gain visibility among global investors and industry leaders. BioUtah will co-host a state bio reception on Sunday night, January 11, 2026, providing networking opportunities for Utah companies with potential partners and investors. The association's presence at this premier healthcare investment conference signals Utah's growing importance in the life sciences landscape and could attract additional capital to the state's innovative companies.
For business and technology leaders, BioUtah's participation demonstrates how regional industry clusters can leverage major conferences to accelerate growth. The life sciences sector represents a key driver of Utah's economy and healthcare advancement, with companies spanning medical device manufacturing and services, research and testing, biotechnology, biopharmaceuticals, and diagnostics. This strategic presence at the J.P. Morgan conference may influence investment patterns and partnership formations in the coming year.
Following the January conference, BioUtah will host the 2026 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit in Salt Lake City on March 12-13, with early bird registration now available. The summit includes a Snowbird ski day, combining business networking with Utah's recreational opportunities. These events collectively position Utah as an emerging hub for life sciences innovation and investment.
The full announcement, including downloadable images and additional information, is available through https://www.reportable.com. BioUtah's participation in these high-profile events reflects the maturation of Utah's life sciences ecosystem and its potential to shape healthcare technology development in coming years. For industry observers, this signals increased competition and innovation in medical technology sectors where Utah companies have established expertise.
